Arcadia Biosciences Annual Income Statement (NASDAQ:RKDA)

Add to My Stocks
$0.69 $0.11 (13.53%) RKDA stock closing price Mar 22, 2017 (Closing)

Financial analysis of Arcadia Biosciences involves more than just checking the Arcadia Biosciences stock price, by looking at the financial statements of the company in detail. The income statement is a summary of the revenue, expenses and profitability (shown as Net Income) or lack of it. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has decreased from $6.98M to $5.41M and how operating and non operating activities have impacted the RKDA stock. 2015 revenue is $5.41M and has decreased from $6.98M year on year as is evident when you compare the latest figures in the latest Arcadia Biosciences profit and loss statement with those of the prior corresponding period. (See also:Arcadia Biosciences assets and Arcadia Biosciences free cash flow) Arcadia Biosciences revenue for 2015 is $5.41M. View revenue and profit details for latest and last 10 financial years.

show more
Fiscal year is Jan - Dec. 2015 2014 2013
Arcadia Biosciences Net Sales or Revenues
5.41M6.98M6.47M
Cost Of Goods Sold (COGS)0.89M1.99M0.67M
Arcadia Biosciences Gross Profit
4.52M4.98M5.8M
Research & Development Expense8.96M10.01M8.4M
Selling General & Admin Expense11.11M10.12M7.96M
Income Before Depreciation Depletion Amortization-15.56M-15.15M-10.56M
Depreciation Depletion Amortization---
Non Operating Income0.29M-0.59M0.01M
Interest Expense2.65M1.39M0.62M
Arcadia Biosciences Pretax Income
-17.93M-17.14M-11.18M
Provision for Income Taxes0.02M0.26M0.16M
Minority Interest---
Investment Gains Losses--0.93M-1.84M
Other Income---
Income Before Extraordinaries & Disc Operations-17.95M-18.33M-13.19M
Extraordinary Items & Discontinued Operations---
Arcadia Biosciences Net Income (Profit/Loss)
-17.95M-18.33M-13.19M
Average Shares used to compute Diluted EPS28.56M2.06M-
Average Shares used to compute Basic EPS28.56M2.06M-
Income Before Nonrecurring Items-17.73M-18.34M-
Income from Nonrecurring Items-0.23M--
Arcadia Biosciences Earnings Per Share Basic Net
-0.73-10.71-
Arcadia Biosciences Earnings Per Share Diluted Net
-0.73-10.71-
EPS Diluted Before Nonrecurring Items-0.72-10.71-
Preferred Dividends Acc Pd---
Dividends Common---
Dividend Per Share Common---
All figures in USD. M: Millions of USD, B: Billions of USD.
Get Income statement for another ticker

The key things to look for in an income statement while doing Arcadia Biosciences stock analysis are:
  • Topline: A growing topline, as seen from the Arcadia Biosciences revenue chart, as is not the case with Arcadia Biosciences indicates a sagging business. One needs to compare the QoQ or YoY topline growth of RKDA stock with its peers like ANDE stock and YONG stock to see if the growth compares well with what can be expected for a company in that industry.
  • Bottom line: Most businesses like Arcadia Biosciences try to improve their bottom line by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.
The income statement is also called the profit and loss statement. Apart from the income statement, one can check the Arcadia Biosciences historical stock prices to check how the price has moved with time. .

Arcadia Biosciences Income Statement - Key Financial Ratios

PS ratio (
price sales ratio
)
9.4978
Operating margin
-363
Net profit margin
-387
Dividend yield
0%